By API User
Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins” before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at … Continued
By API User
The nation’s leading peak body for general practitioners (GP) has warned both sides of Queensland politics not to ignore their advice for a more accessible health system if they want better health outcomes for Queenslanders. The Royal Australian College of General Practitioners (RACGP) will release a report card grading candidates on their response to the … Continued
By API User
Australia continues to be one of the safest countries globally for IVF treatment, the latest data shows. Fewer and fewer twins and triplets are being born through IVF in Australia, bringing IVF and overall Australian multiple birth rates closer together, a new report by UNSW Sydney medical researchers shows. Having twins and triplets … Continued
By API User
SHINE SA and SA Health are proud to celebrate Sexual Health Week, inviting South Australians to have conversations around improving our sexual health and relationship wellbeing. Sexual health is a vital part of our overall wellbeing which makes destigmatising sexual health essential. The theme this year is Pleasure Positive. It follows on from the idea … Continued
By API User
Research using participants from one of Australia’s largest and longest running studies of ageing has looked at the impact of mild cognitive impairment and dementia on a person’s ability to interact in social contexts. Social cognition refers to the set of social skills and abilities that people use to understand and interpret other people’s thoughts … Continued
By API User
ALISO VIEJO, Calif.–BUSINESS WIRE– MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in … Continued
By API User
BOSTON–BUSINESS WIRE– Novotech, a leading full-service clinical Contract Research Organization (CRO), is proud to announce that its Clinical Research Associate (CRA) Monitoring Simulation Program has been recognized with the Brandon Hall Gold Award in the category of Best Competencies and Skill Development. This program is now available to all relevant CRAs in Novotech. This prestigious … Continued
By API User
Phase IV studies demonstrate the consistent safety and high efficacy of MAVENCLAD on NEDA-3, MRI and cognition outcomes over four years New data on blood and CSF biomarkers show the impact of MAVENCLAD to promote immune cell reconstitution, while clinical data confirmed 93.7% of patients free from PIRA MAVENCLAD has now treated more than 100,000 … Continued
By API User
ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic pair which combines therapeutic compound, Debio 0228 ([177Lu]Lu-DPI-4452) and diagnostic imaging agent, Debio 0328 ([68Ga]Ga-DPI-4452) to target Carbonic Anhydrase IX (CA IX) Debiopharm to receive upfront, development and regulatory milestone payments of approximately €300 million, as well as commercial milestones and low … Continued
By API User
Dementia Australia is thrilled to be back for a second year as the nominated charity for the Penrite Oil Sandown 500, one of the greatly anticipated races returning to the Repco Supercars Championships calendar. Supercars, Penrite Racing and Penrite Oil, the major sponsor and partner of the Supercars event, nominated Dementia Australia as their … Continued
